Polyrizon Ltd Ordinary Stock Performance
| PLRZ Stock | 12.85 0.42 3.38% |
Polyrizon holds a performance score of 11 on a scale of zero to a hundred. The company holds a Beta of 4.25, which implies a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Polyrizon will likely underperform. Use Polyrizon semi variance, rate of daily change, and the relationship between the value at risk and kurtosis , to analyze future returns on Polyrizon.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Polyrizon Ltd Ordinary are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of fairly unfluctuating basic indicators, Polyrizon showed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return 3.34 | Five Day Return (0.50) | Year To Date Return 0.75 | Ten Year Return (99.45) | All Time Return (99.45) |
Last Split Factor 1:6 | Last Split Date 2025-11-28 |
1 | US Stocks Edge Higher Dollar General Shares Jump After Upbeat Earnings | 12/04/2025 |
2 | We Think Polyrizon Can Afford To Drive Business Growth | 12/05/2025 |
3 | 12 Health Care Stocks Moving In Mondays Intraday Session | 12/08/2025 |
4 | Polyrizon to Explore Revenue-Generating Real Asset Opportunities, Leveraging Strong Cash Position and Debt-Free Balance Sheet | 12/29/2025 |
5 | As Flu Surge Continues, Polyrizons Nasal Spray Emerges as Potential Extra Shield Solution for Both Vaccinated and Unvaccinated | 01/02/2026 |
6 | Polyrizon Completes Branding Process for PL-14 Allergy Blocker with Brand Name NASARIX | 01/08/2026 |
7 | Polyrizon to Explore Revenue-Generating Investment Opportunities in High-Growth Sectors, Leveraging Strong Cash Position and Debt-Free Balance Sheet | 01/13/2026 |
8 | Polyrizon Advances Regulatory Path with Initiation of Usability Study Program for NASARIX Allergy Blocker | 01/22/2026 |
9 | Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI | 02/06/2026 |
| Begin Period Cash Flow | 4000.00 | |
| Total Cashflows From Investing Activities | 29 K |
Polyrizon | Build AI portfolio with Polyrizon Stock |
Polyrizon Relative Risk vs. Return Landscape
If you would invest 511.00 in Polyrizon Ltd Ordinary on November 11, 2025 and sell it today you would earn a total of 774.00 from holding Polyrizon Ltd Ordinary or generate 151.47% return on investment over 90 days. Polyrizon Ltd Ordinary is currently generating 3.3247% in daily expected returns and assumes 23.8838% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Polyrizon, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Polyrizon Target Price Odds to finish over Current Price
The tendency of Polyrizon Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 12.85 | 90 days | 12.85 | about 23.96 |
Based on a normal probability distribution, the odds of Polyrizon to move above the current price in 90 days from now is about 23.96 (This Polyrizon Ltd Ordinary probability density function shows the probability of Polyrizon Stock to fall within a particular range of prices over 90 days) .
Polyrizon Price Density |
| Price |
Predictive Modules for Polyrizon
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Polyrizon Ordinary. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Polyrizon Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Polyrizon is not an exception. The market had few large corrections towards the Polyrizon's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Polyrizon Ltd Ordinary, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Polyrizon within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 2.50 | |
β | Beta against Dow Jones | 4.25 | |
σ | Overall volatility | 4.24 | |
Ir | Information ratio | 0.12 |
Polyrizon Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Polyrizon for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Polyrizon Ordinary can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Polyrizon Ordinary is way too risky over 90 days horizon | |
| Polyrizon Ordinary appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (1.54 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Polyrizon generates negative cash flow from operations | |
| Polyrizon Ordinary has a poor financial position based on the latest SEC disclosures | |
| About 20.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from globenewswire.com: Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI |
Polyrizon Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Polyrizon Stock often depends not only on the future outlook of the current and potential Polyrizon's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Polyrizon's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 12 K | |
| Cash And Short Term Investments | 2.6 M |
Polyrizon Fundamentals Growth
Polyrizon Stock prices reflect investors' perceptions of the future prospects and financial health of Polyrizon, and Polyrizon fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Polyrizon Stock performance.
| Return On Equity | -0.12 | ||||
| Return On Asset | -0.22 | ||||
| Current Valuation | 13.97 M | ||||
| Shares Outstanding | 1.04 M | ||||
| Price To Book | 0.73 X | ||||
| EBITDA | (1.42 M) | ||||
| Net Income | (1.54 M) | ||||
| Total Debt | 261 K | ||||
| Book Value Per Share | 18.75 X | ||||
| Cash Flow From Operations | (1.15 M) | ||||
| Earnings Per Share | (1.22) X | ||||
| Market Capitalization | 13.38 M | ||||
| Total Asset | 5.55 M | ||||
| Retained Earnings | (5.07 M) | ||||
| Working Capital | 2.39 M | ||||
About Polyrizon Performance
Evaluating Polyrizon's performance through its fundamental ratios, provides valuable insights into its operational efficiency and profitability. For instance, if Polyrizon has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Polyrizon has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements. Please also refer to our technical analysis and fundamental analysis pages.
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.52) | (0.55) | |
| Return On Capital Employed | (0.28) | (0.27) | |
| Return On Assets | (0.25) | (0.26) | |
| Return On Equity | (0.26) | (0.28) |
Things to note about Polyrizon Ordinary performance evaluation
Checking the ongoing alerts about Polyrizon for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Polyrizon Ordinary help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Polyrizon Ordinary is way too risky over 90 days horizon | |
| Polyrizon Ordinary appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (1.54 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Polyrizon generates negative cash flow from operations | |
| Polyrizon Ordinary has a poor financial position based on the latest SEC disclosures | |
| About 20.0% of the company outstanding shares are owned by corporate insiders | |
| Latest headline from globenewswire.com: Clearmind Medicine Enters into Development Agreement to Advance Intranasal Formulation for its Proprietary Non-Hallucinogenic Neuroplastogen MEAI |
- Analyzing Polyrizon's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Polyrizon's stock is overvalued or undervalued compared to its peers.
- Examining Polyrizon's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Polyrizon's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Polyrizon's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Polyrizon's stock. These opinions can provide insight into Polyrizon's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for Polyrizon Stock Analysis
When running Polyrizon's price analysis, check to measure Polyrizon's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Polyrizon is operating at the current time. Most of Polyrizon's value examination focuses on studying past and present price action to predict the probability of Polyrizon's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Polyrizon's price. Additionally, you may evaluate how the addition of Polyrizon to your portfolios can decrease your overall portfolio volatility.